D. Decamp

发表

Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

I. Kuntz, R. DesJarlais, G. Seibel, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Overview of the Alliance for Cellular Signaling

Temple F. Smith, D. Botstein, A. Arkin, 2002, Nature.

A Specific Interaction of Small Molecule Entry Inhibitors with the Envelope Glycoprotein Complex of the Junín Hemorrhagic Fever Arenavirus*

S. Sprang, D. Boger, D. Decamp, 2010, The Journal of Biological Chemistry.

2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers*

Nan Hu, Emanuel F. Petricoin, Michael R. Emmert-Buck, 2002, Molecular & Cellular Proteomics.

Synthesis of a Fullerene Derivative for the Inhibition of HIV Enzymes.

Charles L. Wilkins, Fred Wudl, G. Srdanov, 1993 .

Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification

Fred Wudl, G. Srdanov, Simon H. Friedman, 1993 .

A targeted mass spectrometric analysis of phosphatidylinositol phosphate species Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.D500010-JLR200

D. Decamp, R. Hsueh, H. Brown, 2005, Journal of Lipid Research.

Signaling and Cross-talk by C5a and UDP in Macrophages Selectively Use PLCβ3 to Regulate Intracellular Free Calcium*

M. Simon, D. Decamp, I. Fraser, 2008, Journal of Biological Chemistry.

Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin.

D. Decamp, S. Zein, B. Vash, 1998, Blood.

Peptidomimetic Inhibitors of Human Immunodeficiency Virus Protease ( HIV‐PR): Design, Enzyme Binding and Selectivity, Antiviral Efficacy, and Cell Permeability Properties.

D. Decamp, C. Craik, W. Lowther, 1995 .

Altered Interaction of Cis- dichlorodiammineplatinum(II)–modiﬁed (cid:97) 2 -Macroglobulin ( (cid:97) 2 M) with the Low Density Lipoprotein Receptor-related Protein/ (cid:97) 2 M Receptor but Not the (cid:97) 2 M Signaling Receptor Evidence for Interference with Receptor Dissociation and Recycling

S. Pizzo, D. Decamp, U. K. Misra, 1996 .

Reaction of pyruvate kinase with the new nucleotide affinity labels 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5'-diphosphate and 5'-triphosphate.

D. Decamp, R. Colman, S. Lim, 1988, Biochemistry.

Smoothened activates Galphai-mediated signaling in frog melanophores.

D. Decamp, F. D. de Sauvage, M. Lerner, 2000, The Journal of biological chemistry.

Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway*

D. Decamp, I. Fraser, R. Taussig, 2007, Journal of Biological Chemistry.

Clostridium difficile toxin B differentially affects GPCR‐stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2

D. Decamp, I. Fraser, Keng-mean Lin, 2010, Journal of leukocyte biology.

Three new potential cAMP affinity labels. Inactivation of human platelet low Km cAMP phosphodiesterase by 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphate.

R. Colman, D. Decamp, R. Colman, 1990, Biochemistry.

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.

D. Decamp, C. Craik, W. Howe, 1990, The Journal of biological chemistry.

Haloperidol-based irreversible inhibitors of the HIV-1 and HIV-2 proteases.

P. Ortiz de Montellano, D. Decamp, L. Babe, 1994, Journal of medicinal chemistry.

Smoothened Activates Gαi-mediated Signaling in Frog Melanophores*

D. Decamp, F. D. de Sauvage, M. Lerner, 2000, The Journal of Biological Chemistry.

Unravelling the signal-transduction network in B lymphocytes

Sangdun Choi, Dennis Mock, N. O’Rourke, 2002, Nature.

Synthesis of a fullerene derivative for the inhibition of HIV enzymes

C. Wilkins, D. Decamp, G. L. Kenyon, 1993 .

Identification of residues in α-macroglobulins involved in activation of the α2-macroglobulin signaling receptor

S. Pizzo, D. Decamp, U. K. Misra, 1996 .

Selective Mutations in Cloned and Expressed α-Macroglobulin Receptor Binding Fragment Alter Binding to Either the α2-Macroglobulin Signaling Receptor or the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor*

S. Pizzo, D. Decamp, U. K. Misra, 1996, The Journal of Biological Chemistry.

Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design.

I D Kuntz, I. Kuntz, P. Furth, 1997, The Journal of biological chemistry.

Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active site.

R. Colman, D. Decamp, R. Colman, 1992, Advances in second messenger and phosphoprotein research.

2-[(4-Bromo-2,3-dioxobutyl)thio]-1,N6-ethenoadenosine 5'-diphosphate. A new fluorescent affinity label of a tyrosyl residue in the active site of rabbit muscle pyruvate kinase.

D. Decamp, R. Colman, 1989, Journal of Biological Chemistry.

Affinity Labeling of Adenine Nucleotide Sites in Enzymes

D. Decamp, R. Colman, J. M. Bailey, 1990, Annals of the New York Academy of Sciences.

Modeling species-specific diacylglycerol dynamics in the RAW 264.7 macrophage.

H. Callender, D. Decamp, M. Horn, 2010, Journal of theoretical biology.

Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor.

S. Pizzo, D. Decamp, U. K. Misra, 1996, The Journal of clinical investigation.

Calcium‐free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2

D. Decamp, C. Craik, W. Howe, 1991, Proteins.

Selective mutations in cloned and expressed alpha-macroglobulin receptor binding fragment alter binding to either the alpha2-macroglobulin signaling receptor or the low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.

S. Pizzo, D. Decamp, Y. Yamaguchi, 1996, Journal of Biological Chemistry.

Peptidomimetic inhibitors of human immunodeficiency virus protease (HIV-PR): Design, enzyme binding and selectivity, antiviral efficacy, and cell permeability properties

D. Decamp, C. Craik, W. Lowther, 1993 .

Signaling and Cross-talk by C5a and UDP in Macrophages Selectively Use PLC3 to Regulate Intracellular

M. Simon, D. Decamp, I. Fraser, 2008 .

Structure of a rat α1‐macroglobulin receptor‐binding domain dimer

S. Sprang, D. Decamp, T. Xiao, 2000, Protein science : a publication of the Protein Society.

Signaling and Cross-talk by C5a and UDP in Macrophages Selectively Use PLCβ3 to Regulate Intracellular Free Calcium*

M. Simon, D. Decamp, I. Fraser, 2008, Journal of Biological Chemistry.

Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.

D. Decamp, L. Babe, C. Craik, 1990, The Journal of biological chemistry.

Heterotrimeric G Proteins

S. Sprang, D. Decamp, 2014 .